The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...
Hosted on MSN3mon
Adjuvant anthracycline- plus taxane-based chemotherapy regimen improves survival in high-risk breast cancer patientsChen said that while patients with this type of breast cancer generally receive either adjuvant taxane-based regimens or taxane- and anthracycline-based regimens, there is limited data to guide ...
The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain ...
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...
The FDA approved 177Lu PSMA-617 for prostate-specific membrane antigen-positive metastatic castration-resistant prostate ...
In total, 28 patients received farletuzumab and 46 patients received farletuzumab in combination with standard platinum and taxane chemotherapy. The researchers reported preliminary data from 41 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback